Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Jan 21, 2016

5262_dirs_2016-01-21_7ecd95ae-5a03-4f52-beac-565764d360c7.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6262M

GlaxoSmithKline PLC

21 January 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 21 January 2016, of changes in the interests of the following Persons Discharging Managerial Responsibilities ('PDMR'), following increases in their notional interests in Ordinary Shares, at a price of 1372.50 pence per Share, on the re-investment of dividends paid on 14 January 2016, on Ordinary Shares held in the GlaxoSmithKline Deferred Investment Award Programme.

PDMR Ordinary Shares
Mr R G Connor 416.747
Mr S A Hussain 520.934
Mr D S Redfern 416.747
Ms C Thomas 416.747
Dr P J T Vallance 520.934
Ms E Walmsley 737.963
Mrs V A Whyte 59.217

V A Whyte

Company Secretary

21 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFLQFFXBBV